A panel of DBA/2 T cell hybridomas specific for the sperm whale myoglobin epitope 110-121 was found to recognize antigen presented by the mixed isotype class II molecule EczdAfl a. The response was blocked by monodonal antibodies specific for Ec~ and A/3 a chains; in addition, the hybridomas responded to antigen presented by L cells expressing Ec~A~ a molecules, and made no response with L cells expressing I-A a or I-E d molecules. Two more groups of hybridomas isolated from DBA/2 and B10.D2 mice immunized with myoglobin also recognized peptide 110-121 presented by Ec~aA/3 d. Thus, although it is expressed at biochemically undetectable levels on spleen cells, the E&A/3 a molecule is an important presenting dement in normal H-2 d mice making a conventional immune response to a protein antigen. These results suggest that high levds of class II expression are not a prerequisite for T cell activation.
C
lass II MHC-encoded molecules are heterodimeric membrane proteins that bind peptides and display them on the cell surface for recognition by T lymphocytes. The c~ and chains of class II MHC molecules show very strong preferences for matched isotypic pairing (1, 2) . High level expression of mixed isotype molecules can be achieved after transfection of certain combinations of c~ and/3 gene pairs into L cells (3) (4) (5) . There is also biochemical, serological, and functional evidence for low-level expression on some B cell tumors (4, 6) and human EBV-transformed cells (7) . EozAB molecules can be detected on the spleen ceils of mouse strains with defective E~ expression (8) , and also in mice expressing high levels of an Ec~ transgene (8-10,) where they can be recognized both as alloantigens (9) and as antigen-presenting molecules (10) . Despite these latter results, it was thought that mixed isotype molecules were expressed at levds too low to play any physiological role in individuals with balanced class II chain expression. Here we show that the biochemically undetectable mixed isotype molecule Eo~dA/~ d constitutes a major presenting dement in H-2 a mice for a determinant on sperm whale myoglobin (SpW Mb). 1 The quantitative aspects of this mixed isotype molecule suggest that the very low number of MHC molecules expressed is not limiting s Abbn, t, iatious used in this patxor: LCB, long chain biotinylated; SpW Mb, sperm whale myoglobin.
in T cell activation, and may have important implications for understanding certain autoimmune states.
Materials and Methods
Animals. DBA/2 mice were obtained from The Jackson Laboratory (Bar Harbor, ME) or from the National Cancer Institute (Bethesda, MD). Males, 8-12 wk of age, were used for all experiments.
Antigens. SpW Mb was purchased from Serva (Heidelberg, Germany). SpW Mb peptides and 110-121 SpW Mb long chain biotinylated (LCB) peptide at the NHz terminus were synthesized using standard solid phase methods as previously described (11) .
Antigen-presenting Cells. The L cell transfectants RT 7.7H7 14.3 (EclAt) (3), RT 10.3 C1 (EcxE3 a) (3), RT 2.3.3H D6 (AozdAB a) (12) , and CA36.2.1.Ii (Eo~E3 a and invariant chain) (13) , and the A20 B cell lymphoma line (14) have been previously described. APC were exposed to 3,000 tad from a cesium source before coculture with T cells.
T Cell Hfiridomas. The T cell hybridomas in Table 1 , A and D were obtained by fusion of SpW Mb-specific T cell clones (15, 16) with the BW5147 TCR-cd3-cell line (17) as previously described (18) . Briefly, 3 d before fusion, the T cell clones were restimulated as previously described (16) in the presence of 5 U/ml of human rlL-2 (Cetus Corp., Emeryville, CA). After removal of dead cells on a Ficoll-Paque gradient, 2-10 x 106 cells were fused with 40 x 106 BW5147 cells as described (18) . The antigen fine specificity of the T cell hybridomas was indistinguishable from that of the original T cell clones. The T cell hybridomas in Table 1 , B and C were produced by fusion ofSpW Mb-immune lymph node cells stimulated once in vitro and will be reported elsewhere (K. SeUins et al., manuscript in preparation).
11.2 Assays. 0.1-1 x 10 s hybridoma cells and 0.5-1 x 10 s irradiated APC were cultured with serial dilutions of antigen in flatbottomed microtiter weUs. After a 24-h incubation at 37~ 100 #1 supernatant was harvested from each well, frozen, thawed, and added to 0.5-1.0 x 104 HT-2 cells in 100 #1 medium to measure IL-2 production as Previously described (18) . Plates were pulsed with [3H]TdR (1/~Ci/well) at 20 h, and harvested at 24 h. Results are given as the mean of triplicate wells • SD.
Antibody Blocking. A20 APC (10S/well) were incubated at room temperature for 30 rain with serial twofold dilutions of mAb. 104 hybridoma cells/well and antigen were then added, and the plates incubated for 24 h at 37~ 100/zl supernatant was harvested from each well and assayed for IL-2 as described above.
Peptide Binding Assays. Binding assays with SpW Mb 110-121 LCB peptide were ix-rformed as previously described (11, 19) . Briefly, class II MHC-negative cells; DAP3; Ec~E~, A~At3 a, and Ec~AB a L cell transfectants (3 x 10 s) were incubated in Dulbecco's PBS containing biotinyhted peptide at different concentrations at 37~ for 4 h in 96-well round-bottomed plates. Subsequently, the cells were stained with successive layers of fluoresceinated avidin D (10 /zg/ml in PBS/0.1% BSA; Vector Laboratories, Burlingame, CA), biotinylated anti-avidin D (10 #g/ml in PBS/0.1% BSA; Vector Laboratories), and again fluoresceinated avidin D, each for 30 rain at 4~ The mean fluorescence of 5,000 stained cells was determined by flow cytometry on a FACScan | analyzer (Becton Dickinson Immunochemistry Systems, Mountain View, CA). The background, measured in the absence of peptide, as well as nonspecific binding signal to a class II MHC-negative fibroblast cell line, DAP3, was subtracted from each signal.
Results and Discussion
Analysis of a panel of DBA/2 (H-2 d) SpW Mb-specific T cell clones (20) originally suggested that six independent dones recognized the determinant 110-121 when presented by the EotaE/$ a class II molecule. First, the response could be blocked by the E~-specific mAb 14.4.4S, and was apparently unaffected by the ABa-spedfic antibody MKD6. Second, there was no response to antigen presented by D2.GD spleen ceils; the D2.GD strain has functional A~ a, Aot a, and E~ a genes, but carries a defective Eot allde (21) , and is therefore ActaA/3 a (I-A)+, and EtudE/3 d (I-E)-.
Many of these clones were subsequently fused with the TCR-ot//3-BW5147 variant fusion partner (17) to generate T cell hybridomas, which were assayed on class II-expressing B cells and L cell transfectants. The E~xaE/3 a + L cell line CA 36.2.1Ii, transfected with the EodEB a and invariant chain genes (13), presented antigen very efficiently to the hybridoma 13.26.8-H6, spedfic for an epitope within residues 132-147, confirming the EotaE/3 a presentation of antigen to T cells specific for this epitope (22) . However, CA 36.2.1.Ii cells were unable to present myoglobin or peptide to the 110-121-specific hybridoma 12.2.9-H7. Both hybridomas made excellent control responses to antigen presented by the BALB/c (H-2 a) B lymphoma cell line A20 (data not shown). Similar results were obtained using several other 110-121-specific hybridomas and Ec~aElJa-transfected L cell lines (G. Ruberti, unpublished results).
These experiments suggested that the 110-121-specific hybridomas did not recognize 110-121 presented by EotaEB d, even though the Eot a chain dearly formed part of the presenting molecule. Ec~ d chains expressed in H-2 d cells associated preferentially with EB d chains, but co-transfection experiments have shown that Ect~ can pair with AB a to be expressed as an isotype-mismatched class II molecule (2) (3) (4) . Since all our data were consistent with Ec~dABd-associated recognition of the 110-121 epitope, the antibody inhibition experiments were repeated using higher concentrations of MKD6 and 14.4.4S. The specificity of the antibody preparations is shown in Fig. 1, A and B . MKD6 blocked the response of an AotdABa/106-118-spedfic hybridoma (11.12.8b-H5.1), but had no effect on the response of the Ec~E/3a/132 -147-specific hybridoma 13.26.8-H6. In normal H-2 d cells, with balanced expression of the four class II chains, it has been estimated that Eo~A3 a molecules account for <5% of the class II molecules (2) . To test this, L cells (AoeaA3 d, Ec~E3 d, or EoeA3 a) expressing MHC molecules at levels similar to that on A20 and H-2 a spleen cells were compared for their ability to present myoglobin peptides to the various hybridomas. For AotaA~ a- (Fig. 2 D) and Ec~aE3 d- (Fig. 2 C) restricted responses, the L cells gave dose response curves very similar to those seen with A20 and H-2 d spleen cells. In contrast, the EoLA3d-transfected L cells allowed half-maximal responses at peptide concentrations three to five orders of magnitude lower than with A20 or H-2 a spleen cells (Fig. 2, A and B) . These results were consistent with very low expression of EolaA3 a relative to Act, dA~ d and There has been considerable debate about any function in vivo for mixed isotype class II molecules (2, 23) . The crucial issue concerns the level of cell surface expression, rather than any special properties of mismatched ol/B pairs. Activation of class II-specific T cells in the periphery depends critically on class II density on the APC (24) (25) (26) . Mixed isotype class II molecules, when expressed at sufficiently high levels, appear to have properties indistinguishable from those ofisotypematched molecules. They can be recognized as alloantigens (9) , present conventional protein antigens (4, 6, 10) , and can also cause partial deletion of T cell subsets in Mls-positive mice (8) . However, the association of class II chains is influenced by strong isotype and haplotype preferences in o~/B pairing (2) (3) (4) (27) (28) (29) , so that cells with balanced Ac~, AB, Eo~, and E~ chain synthesis express low or undetectable amounts of mixed isotype molecules. In previous reports, mixed isotype molecules have been recognized by T cells only when their expression is favored by co-transfection of particular dass II ol or ~ chains (4), by unbalanced synthesis of the isotypically matched c~ or ~ chain (6) (7) (8) , or by the introduction of Eot transgenes expressed at high levels (8) (9) (10) ).
The present study shows that normal mice with balanced class II c~ and B chain synthesis can use isotypically mismatched molecules in a conventional immune response, even though these molecules are expressed at such low levels, relative to the isotypically matched class II molecules, that they can be biochemically undetectable on spleen cells (2, and R. Getmain, unpublished results). These results suggest that high levels of class II expression are not a prerequisite for T cell activation. It is not possible to say from these experiments whether the low level of class II expression required for acti-vation in the periphery reflects equally low thresholds for positive or negative selection in the thymus; it has been shown by others that levels of class II expression too low to stimulate antigen-specific or allogeneic responses nevertheless induce tolerance to much higher levels of the same class II molecule (9, 10, 30) . These data raise questions about the role that mismatched MHC molecules might play in a physiological immune or autoimmune response without the necessity of invoking any unbalanced expression of isotype-matched chains (2, 23) . Antigen presentation by mixed isotype molecules may well depend both on the particular antigen and on the available TCtL repertoire. Presentation by mixed isotype molecules in vivo would greatly increase the repertoire of class II-restricted T cell responses, especially in humans, where individuals heterozygous for DR, DQ, and DP alleles potentially express a very large number of different dass II molecules. Certain autoimmune diseases correlate with extended HLA-D haplotypes, rather than with particular DR, DQ, or DP alleles (31) (32) (33) . Our results support the possibility that these diseases are induced or maintained by responses involving mixed isotype molecules (23).
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